Trial
NCT01273402
Study of TF2 Carcinoembryonic Antigen (CEA) Antibody in Patients With Metastatic Colorectal Cancer
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Gilead Sciences
Collaborators
National Cancer Institute (NCI)
Condition
Metastatic Colorectal Cancer
Intervention
TF2/IMP288
Why stopped
A new study is being designed. No patients were enrolled.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-08-16